申请人:Yamanouchi Pharmaceutical Co. Ltd.
公开号:US06673799B1
公开(公告)日:2004-01-06
This application relates to a piperazino-substituted novel cyanophenyl derivative in which a substituted carbamoyl or substituted sulfamoyl group having an aryl, heterocyclic or the like group that may have a substituent group is bonded to one nitrogen atom on the piperazine ring. The compound of this application has an anti-androgen action and is useful in preventing or treating prostatic cancer, benign prostatic hyperplasia and the like diseases.
该申请涉及一种哌嗪取代的新型氰基苯基衍生物,其中带有芳基、杂环或类似的基团的取代羰酰基或取代磺酰基与哌嗪环上的一个氮原子结合。该申请的化合物具有抗雄激素作用,并可用于预防或治疗前列腺癌、良性前列腺增生等疾病。